Our day-to-day at Memorias del IICS

A glimpse into our day-to-day at the Memorias del IICS office

Leer más

About

Memorias del Instituto de Investigaciones en Ciencias de la Salud (Mem. Inst. Investig. Cienc. Salud) is the official publication of the Institute of Research in Health Sciences (IICS) of the National University of Asunción (UNA), Paraguay. It publishes original scientific contributions in clinical medicine, biomedical research, microbiology, molecular biology, dentistry, nursing, nutrition, public health, health biotechnology, genetics, biochemistry, and related disciplines. Founded in 1983, the journal adopted its current name in 2002 and has been published exclusively online since 2015, incorporating XML article dissemination as of 2024. Since 2023, it operates under a continuous publication model. The journal accepts manuscripts in Spanish and English as original research articles, reviews, case studies, and brief communications. All content is available in open access, free of charge for authors and readers, under the Creative Commons Attribution 4.0 International License, in accordance with the Budapest Open Access Initiative (BOAI). It is indexed in BVS, SciELO Paraguay, HINARI, LILACS, DOAJ, Latindex, MIAR, Dialnet, CiteFactor, Google Scholar, LivRe, BASE, EBSCO, and Web of Science – SciELO Citation Index. The journal is funded by IICS-UNA, supports the OAI-PMH protocol for metadata harvesting, and uses the LOCKSS system for digital preservation of its contents.

 
Leer más

Peer Review Process

Manuscripts submitted to Memorias del Instituto de Investigaciones en Ciencias de la Salud undergo a double-blind peer review process, in which the identities of both authors and reviewers remain anonymous throughout the evaluation. Each manuscript is assessed by a minimum of two external reviewers with expertise in the relevant subject area, who are given a period of 30 days to submit their evaluation. Reviewers assess the originality, methodological rigor, scientific relevance, and clarity of presentation of each work. Based on the reviewers' reports, the Editorial Committee decides whether to accept, request revisions, or reject the manuscript, and communicates the decision to the authors as promptly as possible. This process ensures impartiality, transparency, and the scientific quality of published articles.

Leer más

Call for Papers

The Institute of Research in Health Sciences (IICS) of the National University of Asunción (UNA) invites researchers, academics, and health professionals to submit their manuscripts for consideration in the 2026 Volume of Memorias del Instituto de Investigaciones en Ciencias de la Salud (Mem. Inst. Investig. Cienc. Salud). The journal accepts original and unpublished contributions in Spanish as original research articles, review articles, case studies, and brief communications, in the areas of clinical medicine, biomedical research, microbiology, molecular biology, dentistry, nursing, nutrition, public health, health biotechnology, genetics, biochemistry, and related disciplines. The call for submissions is open and ongoing, and manuscripts may be submitted at any time of the year through the journal's online submission system. All received manuscripts undergo double-blind peer review. The journal is open access, with no charges for authors or readers. For further information on submission guidelines, please refer to the author instructions available on the journal's website.

Leer más

Determinación de la sensibilidad in vitro de diferentes cepas de Trypanosoma cruzi al benznidazol y al extracto de hoja de la planta Zanthoxylum chiloperone

Authors

  • R Hamuy
  • Nidia Acosta Author
  • Elsa López Author
  • Maria Elena Ferreira Author
  • Ninfa Vera de Bilbao Author

Keywords:

Trypanosoma cruzi, benznidazol, in vitro, sensibilidad, v

Abstract

Se evaluó la sensibilidad in vitro al benznidazol y al extracto de hojas de la planta Zanthoxylum chiloperone de diez cepas del Trypanosoma cruzi. Se utilizaron formas epimastigotas de las cepas, pertenecientes a diferentes linajes, diferente procedencia geográfica, incluidas tres de Paraguay, y aisladas de hospederos distintos, abarcando humanos, triatominos y animales silvestres. El grado de sensibilidad a la droga y al extracto vegetal fue estimado por el porcentaje de lisis de los parásitos a las 24 y 48 horas de exposición. Se observó un amplio rango de variación en el porcentaje de lisis entre las cepas, de 22,2% a 90,8% a la concentración del benznidazol de 200 μg/mL, con el hallazgo de una cepa con sensibilidad nula al mismo. Con respecto al extracto vegetal, tres concentraciones fueron testadas, de 500, 700 y 900 μg/mL, observándose variaciones en los porcentajes de lisis entre las cepas con las dos primeras concentraciones, entre un 2,1% y 100%, con lisis total en todas las cepas a la concentración de 900 μg/mL. No se observó asociación entre la diversidad de respuesta a los compuestos y la clasificación de las cepas ni con su origen geográfico y tipo de hospedero. Estas diferencias observadas resaltan la heterogeneidad de las poblaciones naturales del T. cruzi, aspecto importante a tener en cuenta en los estudios de sensibilidad a quimioterapéuticos y en los tamizajes primarios de nuevos antichagásicos. Así mismo, se destaca la eficacia del extracto vegetal sobre diferentes cepas de este parásito.

Downloads

Download data is not yet available.

References

Añez N, Carrasco H, Parada H, Crisante G, Rojas A, Fuenmayor C, Gonzalez N, Percoco G, Borges R, Guevara P, Ramirez JL. Myocardial parasite persistence in chronic chagasic patients. Am J Trop Med Hyg.1999; 60:726-32.

World Health Organization. First WHO report on neglected tropical diseases: working to overcome the global impact of neglected tropical diseases.WHO/HTM/NTD.2010.

Llewellyn MS, Lewis MD, Acosta N, Yeo M, Carrasco HJ, Segovia M, et al. Trypanosoma cruzi IIc: phylogenetic and phylogeographic insights from sequence and microsatellite analysis and potential impact on emergent Chagas disease. PLoS Negl Trop Dis. 2009;3:e510.

Schofield C, Jannin J, Salvatella R. The Future of Chagas disease control.Trends Parasitol.2006; 22:583-8.

López-Antuñano FJ. Quimioterapia de la infecciones producidas por Trypanosoma cruzi. Salud Pública de Méx. 1997; 39:463-71.

Zingales B, Andrade SG, Briones MR, Campbell DA, Chiari E, Fernandes O, et al. Second Satellite Meeting. A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem Inst Oswaldo Cruz. 2009; 104:1051-4.

Zingales B, Miles MA, Campbell DA, Tibayrenc M, Macedo AM, Teixeira MM, et al. The revised Trypanosoma cruzi subspecific nomenclature: rationale, epidemiological relevance and research applications. Infect Genet Evol. 2012; 12:240-53.

Tibayrenc M. Genetic epidemiology of parasitic protozoa and other infectious agents: the need for an integrated approach. Int J Parasitol. 1998; 28:85-104.

Guzmán E, Zabala J, Acosta K, Rosado M. Importancia de la caracterización de cepas de Trypanosoma cruzi. Rev Biomed. 1999;10:177-84.

Sosa-Estani E, Segura E. Tratamiento de la infección por Trypanosoma cruzi en fase indeterminada. Experiencia y normalización en la Argentina. Medicina, Buenos Aires. 1999;57:13-4.

Tarleton R. Chagas disease: a role for autoimmunity?.Trends Parasitol. 2003;19:447-51.

Beaumier CM, Gillespie PM, Hotez PJ, Bottazzi ME. New vaccines for neglected parasitic diseases and dengue.Transl Res. 2013; 162:144-55.

Stoppani A. Quimioterapia de la Enfermedad de Chagas. Medicina, Buenos Aires. 1999; 59:147-65.

Milliken W. Plants for Malaria, Plants for Fever: Medicinal Species in Latin America–a Bibliographic Survey. Kew Publishing. 1997; p.122.

Thouvenel C, Gantier J, Duret, P, Fourneau C, Hocquemiller R, Ferreira M, et al. Antifungal compounds from Zanthoxylum chiloperone var. angustifolium. Phytotherapy Research. 2003; 17:678–80.

Ferreira ME, Rojas de Arias A, Torres de Ortiz S, Inchausti A, Nakayama H, Thouvenel C, et al. Leishmanicidal activity of canthin-6-one alkalloids isolated from Zanthoxylum chiloperone var. angustifolium. J Ethnopharmacol. 2002;80:199–202

Hamuy R y col.: 25-25 25

Ferreira ME, Nakayama H, de Arias AR, Schinini A, de Bilbao NV, Serna E, et al. Effects of canthin-6-one alkaloids from Zanthoxylum chiloperone on Trypanosoma cruzi-infected mice. J Ethnopharmacol. 2006; 109:258-63.

Ferreira ME, Cebrián-Torrejón G, Corrales AS, Vera de Bilbao N, Rolón M, Gomez CV, et al. Zanthoxylum chiloperone leaves extract: first sustainable Chagas disease treatment. J Ethnopharmacol.2011; 133:986-93.

Urbina J. Parasitological Cure of Chagas Disease: Is it Possible?, Is it Relevant?. Mem Inst Oswaldo Cruz. 1999; 94:349-55.

Vera de Bilbao N, Samudio M, Schinini A, Acosta N, López E, González N, et al. Evaluacióna 24 meses post-tratamiento con Benznidazol en niños de 6 a 12 años infectados con Trypanosoma cruzi. Rev Patol Trop. 2004; 33:301-312.

Vera de Bilbao N, Elías E, Martínez J, Carpinelli de Tomassone M, Torres S, Sosa L, Díaz V. Evolución serológica y parasitológica post-tratamiento de pacientes con enfermedad de Chagas crónica reciente. Mem.Inst. Investig.Cienc.Salud.2006; 2:5-10.

Camargo E. Growth and differentiation in Trypanosoma cruzi I. Origen of metacyclic trypanosomes in liquid media. Rev Inst Med Trop Sao Paulo. 1964;6:93-100.

Brisse S, Verhoef J, Tibayrenc M. Characterization of large and small subunit rRNA and mini-exon genes further supports the distinction of six Trypanosoma cruzi lineages. Int J Parasitol. 2001; 31:1218-26.

Neves A, Soares J, da Silva J, Cavadinha R, Marques A, Rolim P. Development of dissolution method for benznidazole tablets. Quim Nova. 2009; 32:2196-9.

Schiplander MT, Mitscher LA. A facile one-step synthesis of benz (4,5) canthin-6-one. J Hetero Chemis. 1971; 8:695-96.

Grosso NL, Bua J, Perrone AE, Gonzalez MN, Bustos PL, Postan M, et al. Trypanosoma cruzi: biological characterization of a isolate from an endemic area and its susceptibility to conventional drugs. Exp arasitol. 2010; 126:239-44.

Luna K, Hernández I, Rueda C, Zorro M, Croft S, Escobar P. In vitro susceptibility of Trypanosoma cruzi strains from Santander, Colombia, to hexadecylphosphocholine (miltefosine), nifurtimox and benznidazole. Biomédica.2009; 29:448-55.

Mejía-Jaramillo AM, Fernández GJ, Montilla M, Nicholls RS, Triana-Chávez O. Trypanosoma cruzi strains resistant to benznidazole occurring in Colombia. Biomédica. 2012; 32:196-205.

Martínez-Díaz RA, Escario JA, Nogal-Ruiz JJ, Gómez-Barrio A. Biological characterization of Trypanosoma cruzi strains. Mem Inst Oswaldo Cruz. 2001; 96:53-9.

Muñoz-Calderón A, Santaniello A, Pereira A, Yannuzzi J, Díaz-Bello Z, Alarcón de Noya B. Susceptibilidad in vitro a Nifurtimox y Benznidazol de aislados de Trypanosoma cruzi obtenidos de pacientes venezolanos con enfermedad de Chagas infectados por mecanismos de transmisión oral y vectorial. Rev Ibero-Latinoam Parasitol. 2012; 71:14-22.

Revollo S, Oury B, Laurent JP, Barnabe C, Quesney V, Carriere V. Trypanosoma cruzi: impact of clonal evolution of the parasite on its biological and medical properties. Exp Parasitol. 1998;89:30-9.

Veloso V, Carneiro C, Toledo M, Lana M, Chiari E, Tafuri W, et al. Variation in Susceptibility to Benznidazole in Isolates Derived from Trypanosoma cruzi Parental Strains. Mem Inst Oswaldo Cruz Vol. 2001;96:1005-11.

Filardi L, Brener Z. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Trans R Soc Trop Med Hyg.1987; 81:755-9.

Villarreal D, Barnabé C, Sereno D, Tibayrenc M. Lack of correlation between in vitro susceptibility to Benznidazole and phylogenetic diversity of Trypanosoma cruzi, the agent of Chagas disease. Exp Parasitol. 2004; 108:24-31.

Dos Santos FM, Caldas S, de AssisCáu SB, Crepalde GP, de Lana M, Machado-Coelho GL, et al. Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection. Exp Parasitol. 2008;120:385-90.

Mejia AM, Hall BS, Taylor MC, Gómez-Palacio A, Wilkinson SR, Triana-Chávez O, et al. Benznidazole-resistance in Trypanosoma cruzi is a readily acquired trait that can arise independently in a single population. J Infect Dis. 2012; 206:220-8.

Downloads

Published

2013-12-01

Issue

Section

Original Articles

How to Cite

Hamuy, R., Acosta, N., López, E., Ferreira, M. E., & Vera de Bilbao, N. (2013). Determinación de la sensibilidad in vitro de diferentes cepas de Trypanosoma cruzi al benznidazol y al extracto de hoja de la planta Zanthoxylum chiloperone. Memorias Del Instituto De Investigaciones En Ciencias De La Salud, 11(2). https://revistascientificas.una.py/index.php/RIIC/article/view/1752